# clm_45941C7F343F

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 6,085,700,000 United States dollar  
valid_from: 2020-12-31  
valid_to: 2021-12-31  
published: 2021-02-17  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_92775F3E7CB5  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 6,085,700,000 United States dollar", as of 2020-12-31 (until 2021-12-31). Claim clm_45941C7F343F, https://asof.is/claim/clm_45941C7F343F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000083/0000059478-21-000083-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2020, filed 2021-02-17  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947821000083/0000059478-21-000083-index.htm (primary, SEC EDGAR 10-K FY2020, published 2021-02-17)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 5,595,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_45941C7F343F](/claim/clm_45941C7F343F.md) | [clm_7AE5F777CC93](/claim/clm_7AE5F777CC93.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.